Shannon Takala-Harrison1, Christopher G Jacob1, Cesar Arze2, Michael P Cummings3, Joana C Silva2, Arjen M Dondorp4, Mark M Fukuda5, Tran Tinh Hien6, Mayfong Mayxay7, Harald Noedl8, Francois Nosten9, Myat P Kyaw10, Nguyen Thanh Thuy Nhien6, Mallika Imwong11, Delia Bethell5, Youry Se12, Chanthap Lon12, Stuart D Tyner5, David L Saunders5, Frederic Ariey13, Odile Mercereau-Puijalon14, Didier Menard15, Paul N Newton16, Maniphone Khanthavong17, Bouasy Hongvanthong17, Peter Starzengruber8, Hans-Peter Fuehrer8, Paul Swoboda8, Wasif A Khan18, Aung Pyae Phyo19, Myaing M Nyunt1, Myat H Nyunt10, Tyler S Brown1, Matthew Adams1, Christopher S Pepin1, Jason Bailey1, John C Tan20, Michael T Ferdig21, Taane G Clark22, Olivo Miotto23, Bronwyn MacInnis24, Dominic P Kwiatkowski25, Nicholas J White4, Pascal Ringwald26, Christopher V Plowe1. 1. Howard Hughes Medical Institute/Center for Vaccine Development. 2. Institute for Genome Sciences, University of Maryland School of Medicine, Baltimore. 3. Center for Bioinformatics and Computational Biology, University of Maryland, College Park. 4. Mahidol-Oxford Tropical Medicine Research Unit. 5. Armed Forces Research Institute of Medical Sciences, Bangkok. 6. Center for Tropical Medicine, Oxford University Clinical Research Unit, Ho Chi Minh City, Vietnam. 7. Lao-Oxford-Mahosot Hospital-Wellcome Trust Research Unit, Microbiology Laboratory, Mahosot Hospital Faculty of Postgraduate Studies, University of Health Sciences Centre for Tropical Medicine, Nuffield Department of Medicine, University of Oxford. 8. Institute of Specific Prophylaxis and Tropical Medicine, Medical University of Vienna, Austria. 9. Mahidol-Oxford Tropical Medicine Research Unit Centre for Tropical Medicine, Nuffield Department of Medicine, University of Oxford. 10. Department of Medical Research (Lower Myanmar), Yangon. 11. Department of Molecular Tropical Medicine and Genetics, Faculty of Tropical Medicine, Mahidol University. 12. Armed Forces Research Institute of Medical Sciences. 13. GGIV Unit, Parasitology and Mycology Departement. 14. Parasite Molecular Immunology Unit, Institut Pasteur, Paris, France. 15. Malaria Molecular Epidemiology Unit, Institut Pasteur du Cambodge, Phnom Penh, Cambodia. 16. Lao-Oxford-Mahosot Hospital-Wellcome Trust Research Unit, Microbiology Laboratory, Mahosot Hospital Centre for Tropical Medicine, Nuffield Department of Medicine, University of Oxford. 17. Center of Malariology, Parasitology, and Entomology, Vientiane, Laos. 18. International Centre for Diarrhoeal Disease Research, Dhaka, Bangladesh. 19. Mahidol-Oxford Tropical Medicine Research Unit Shoklo Malaria Research Unit Mahidol-Oxford Tropical Medicine Research Unit, Faculty of Tropical Medicine, Mahidol University, Mae Sot, Thailand. 20. Research and Development, Roche NimbleGen, Madison, Wisconsin. 21. Eck Institute for Global Health, Department of Biological Sciences, University of Notre Dame, Indiana. 22. Faculty of Epidemiology and Population Health Faculty Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine. 23. Mahidol-Oxford Tropical Medicine Research Unit MRC Centre for Genomics and Global Health, Oxford University and Wellcome Trust Sanger Institute Malaria Programme, Wellcome Trust Sanger Institute, Hinxton, United Kingdom. 24. Malaria Programme, Wellcome Trust Sanger Institute, Hinxton, United Kingdom. 25. MRC Centre for Genomics and Global Health, Oxford University and Wellcome Trust Sanger Institute Malaria Programme, Wellcome Trust Sanger Institute, Hinxton, United Kingdom. 26. Drug Resistance and Containment Unit, Global Malaria Programme, World Health Organization, Geneva, Switzerland.
Abstract
BACKGROUND: The emergence of artemisinin-resistant Plasmodium falciparum in Southeast Asia threatens malaria treatment efficacy. Mutations in a kelch protein encoded on P. falciparum chromosome 13 (K13) have been associated with resistance in vitro and in field samples from Cambodia. METHODS: P. falciparum infections from artesunate efficacy trials in Bangladesh, Cambodia, Laos, Myanmar, and Vietnam were genotyped at 33 716 genome-wide single-nucleotide polymorphisms (SNPs). Linear mixed models were used to test associations between parasite genotypes and parasite clearance half-lives following artesunate treatment. K13 mutations were tested for association with artemisinin resistance, and extended haplotypes on chromosome 13 were examined to determine whether mutations arose focally and spread or whether they emerged independently. RESULTS: The presence of nonreference K13 alleles was associated with prolonged parasite clearance half-life (P = 1.97 × 10(-12)). Parasites with a mutation in any of the K13 kelch domains displayed longer parasite clearance half-lives than parasites with wild-type alleles. Haplotype analysis revealed both population-specific emergence of mutations and independent emergence of the same mutation in different geographic areas. CONCLUSIONS: K13 appears to be a major determinant of artemisinin resistance throughout Southeast Asia. While we found some evidence of spreading resistance, there was no evidence of resistance moving westward from Cambodia into Myanmar.
BACKGROUND: The emergence of artemisinin-resistant Plasmodium falciparum in Southeast Asia threatens malaria treatment efficacy. Mutations in a kelch protein encoded on P. falciparum chromosome 13 (K13) have been associated with resistance in vitro and in field samples from Cambodia. METHODS: P. falciparum infections from artesunate efficacy trials in Bangladesh, Cambodia, Laos, Myanmar, and Vietnam were genotyped at 33 716 genome-wide single-nucleotide polymorphisms (SNPs). Linear mixed models were used to test associations between parasite genotypes and parasite clearance half-lives following artesunate treatment. K13 mutations were tested for association with artemisinin resistance, and extended haplotypes on chromosome 13 were examined to determine whether mutations arose focally and spread or whether they emerged independently. RESULTS: The presence of nonreference K13 alleles was associated with prolonged parasite clearance half-life (P = 1.97 × 10(-12)). Parasites with a mutation in any of the K13 kelch domains displayed longer parasite clearance half-lives than parasites with wild-type alleles. Haplotype analysis revealed both population-specific emergence of mutations and independent emergence of the same mutation in different geographic areas. CONCLUSIONS: K13 appears to be a major determinant of artemisinin resistance throughout Southeast Asia. While we found some evidence of spreading resistance, there was no evidence of resistance moving westward from Cambodia into Myanmar.
Authors: James G Kublin; Fraction K Dzinjalamala; Deborah D Kamwendo; Elissa M Malkin; Joseph F Cortese; Lisa M Martino; Rabia A G Mukadam; Stephen J Rogerson; Andres G Lescano; Malcolm E Molyneux; Peter A Winstanley; Phillips Chimpeni; Terrie E Taylor; Christopher V Plowe Journal: J Infect Dis Date: 2002-01-17 Impact factor: 5.226
Authors: A Djimdé; O K Doumbo; J F Cortese; K Kayentao; S Doumbo; Y Diourté; D Coulibaly; A Dicko; X Z Su; T Nomura; D A Fidock; T E Wellems; C V Plowe Journal: N Engl J Med Date: 2001-01-25 Impact factor: 91.245
Authors: Christopher G Jacob; John C Tan; Becky A Miller; Asako Tan; Shannon Takala-Harrison; Michael T Ferdig; Christopher V Plowe Journal: BMC Genomics Date: 2014-08-26 Impact factor: 3.969
Authors: Shannon Takala-Harrison; Taane G Clark; Christopher G Jacob; Michael P Cummings; Olivo Miotto; Arjen M Dondorp; Mark M Fukuda; Francois Nosten; Harald Noedl; Mallika Imwong; Delia Bethell; Youry Se; Chanthap Lon; Stuart D Tyner; David L Saunders; Duong Socheat; Frederic Ariey; Aung Pyae Phyo; Peter Starzengruber; Hans-Peter Fuehrer; Paul Swoboda; Kasia Stepniewska; Jennifer Flegg; Cesar Arze; Gustavo C Cerqueira; Joana C Silva; Stacy M Ricklefs; Stephen F Porcella; Robert M Stephens; Matthew Adams; Leo J Kenefic; Susana Campino; Sarah Auburn; Bronwyn MacInnis; Dominic P Kwiatkowski; Xin-zhuan Su; Nicholas J White; Pascal Ringwald; Christopher V Plowe Journal: Proc Natl Acad Sci U S A Date: 2012-12-17 Impact factor: 11.205
Authors: Mindy Leelawong; Nicholas M Adams; William E Gabella; David W Wright; Frederick R Haselton Journal: J Mol Diagn Date: 2019-06-13 Impact factor: 5.568
Authors: Amed Ouattara; Aminatou Kone; Matthew Adams; Bakary Fofana; Amelia Walling Maiga; Shay Hampton; Drissa Coulibaly; Mahamadou A Thera; Nouhoum Diallo; Antoine Dara; Issaka Sagara; Jose Pedro Gil; Anders Bjorkman; Shannon Takala-Harrison; Ogobara K Doumbo; Christopher V Plowe; Abdoulaye A Djimde Journal: Am J Trop Med Hyg Date: 2015-04-27 Impact factor: 2.345
Authors: Costanza Tacoli; Prabhanjan P Gai; Claude Bayingana; Kevin Sifft; Dominik Geus; Jules Ndoli; Augustin Sendegeya; Jean Bosco Gahutu; Frank P Mockenhaupt Journal: Am J Trop Med Hyg Date: 2016-08-29 Impact factor: 2.345